HANNA SONG: Open Payments
NPI 1174134472 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 29 payments from 12 companies in 2025. Trend: 2023 $1,038 · 2024 $389 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $154 |
| JAZZ PHARMACEUTICALS INC. | 3 | $90 |
| Daiichi Sankyo Inc. | 3 | $68 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $61 |
| Genentech USA, Inc. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $46 |
| ABBVIE INC. | 2 | $41 |
| PFIZER INC. | 1 | $38 |
| Incyte Corporation | 1 | $22 |
| Eisai Inc. | 1 | $18 |
Products named: SCEMBLIX, RYLAZE, Venclexta, Vanflyta, LifeVest, Vyloy, TIVDAK, Fabhalta.
Industry payments across CA — which companies pay providers there.
